Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex® Tablet 80 mg

NCT00919477 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00919477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00919477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex® Tablet 80 mg
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
May 31, 2009
Completion date
March 31, 2012
Enrollment
712 (actual)
Sites
160

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer